NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/02/2024
Back to search
Official data from USPTO
ALLOPLEX BIOTHERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALLOPLEX BIOTHERAPEUTICS
ST13
US500000088362634Class
42
Filing
88362634
Registration
7262347
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
01/02/2024
Trademark type
Word
Nice classes
42
Filing date
03/29/2019
Registration date
01/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2024
Last transaction
01/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2022
First use in commerce
01/01/2022
Drawing code
4
Owner type
03
Owner location
Winchester, MA
Examiner
WRIGHT, MARCO JABBAR
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Alloplex Biotherapeutics, Inc.
Representatives
Kelly J. Garrone MCCARTER & ENGLISH, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing medical and scientific research information in the field of immuno-oncology; scientific research and development; and scientific research consulting in the field of immuno-oncology
Publications
History of USPTO decisions and trademark events.
50 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/01/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/30/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/09/2023
IUAF
USE AMENDMENT FILED
10/10/2023
EISU
TEAS STATEMENT OF USE RECEIVED
10/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/30/2023
EX5G
SOU EXTENSION 5 GRANTED
03/29/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/29/2023
EXT5
SOU EXTENSION 5 FILED
03/17/2023
EEXT
SOU TEAS EXTENSION RECEIVED
03/17/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/06/2022
EX4G
SOU EXTENSION 4 GRANTED
10/04/2022
EXT4
SOU EXTENSION 4 FILED
10/04/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/04/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/08/2022
EX3G
SOU EXTENSION 3 GRANTED
04/06/2022
EXT3
SOU EXTENSION 3 FILED
04/06/2022
EEXT
SOU TEAS EXTENSION RECEIVED
04/06/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/08/2021
EX2G
SOU EXTENSION 2 GRANTED
10/06/2021
EXT2
SOU EXTENSION 2 FILED
10/06/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/06/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/10/2021
EX1G
SOU EXTENSION 1 GRANTED
04/08/2021
EXT1
SOU EXTENSION 1 FILED
04/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/08/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/20/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/25/2020
PUBO
PUBLISHED FOR OPPOSITION
08/25/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/05/2020
ALIE
ASSIGNED TO LIE
07/20/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/17/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
07/16/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/16/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
07/16/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/16/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/31/2019
GNFR
FINAL REFUSAL E-MAILED
12/31/2019
CNFR
FINAL REFUSAL WRITTEN
12/31/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/11/2019
GNRT
NON-FINAL ACTION E-MAILED
06/11/2019
CNRT
NON-FINAL ACTION WRITTEN
06/11/2019
DOCK
ASSIGNED TO EXAMINER
06/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/17/2019
NWAP
NEW APPLICATION ENTERED
04/02/2019
Continuous trademark protection
Get notified about every new filing that threatens ALLOPLEX BIOTHERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.